Vitamin B9 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pharmaceutical, Food, Animal Feed ,Cosmetic & Personal Care, Others), By Region and Competition, 2020-2030F
Market Overview
The Global Vitamin B9 Market was valued at USD 87.10 Million in 2024 and is projected to reach USD 106.91 Million by 2030, growing at a CAGR of 2.45%. Vitamin B9, also known as folate or folic acid, is essential for DNA synthesis, red blood cell production, and fetal development, making it a critical nutrient across various life stages, particularly during pregnancy. Rising focus on preventive healthcare and increased consumer awareness about nutritional deficiencies are driving demand for Vitamin B9 supplements, especially in North America and Europe. Government initiatives aimed at reducing anemia and neural tube defects in newborns have further encouraged folic acid fortification and supplementation. However, the market faces obstacles such as regulatory complexities, raw material price fluctuations, and the potential side effects of excessive intake. Despite these challenges, ongoing R&D investments, strategic partnerships, and expansion into underpenetrated regions are expected to shape the market's growth trajectory.
Key Market Drivers
Growth in Pharmaceutical Industry
The expanding pharmaceutical industry serves as a key driver for the Vitamin B9 market, fueled by the sector’s focus on disease prevention, prenatal health, and nutritional therapies. By 2023, the pharmaceutical market had reached revenues of approximately USD 1.6 trillion, highlighting its global scale and influence. Vitamin B9 is indispensable in therapeutic applications due to its roles in cell division, DNA synthesis, and hematopoiesis. It is extensively used in prenatal supplements to prevent neural tube defects and is increasingly incorporated into treatments for anemia, cognitive decline, and cardiovascular health. The market has seen innovations like Manna iStrong, a fortified drink launched by Southern Health Foods Pvt Ltd. in India, which delivers 100% of the RDA for Vitamin B9 among others. In regions where fortified foods are less accessible, pharmaceutical-grade supplements are vital, particularly in maternal and elderly care segments.
Key Market Challenges
Raw Material Supply Disruptions
Raw material supply instability presents a significant hurdle for Vitamin B9 manufacturers. The market is highly dependent on specific chemical intermediates and ingredients, predominantly sourced from a few global suppliers. Events such as geopolitical tensions, trade regulations, and natural disasters, as well as pandemics like COVID-19, have exposed vulnerabilities in the global supply chain. Countries such as China and India play critical roles in supplying active pharmaceutical ingredients (APIs) and intermediates, meaning regulatory changes or environmental policy shifts in these regions can disrupt production. These constraints not only elevate costs but also introduce delays and uncertainty for manufacturers, particularly small and medium-sized enterprises.
Key Market Trends
Increasing Demand for Dietary Supplements
The growing global emphasis on preventive healthcare is fueling demand for dietary supplements, making it a defining trend in the Vitamin B9 market. Consumers are increasingly turning to supplements to support immune function, address nutritional gaps, and reduce disease risk. Folic acid’s inclusion in multivitamins and prenatal products is becoming more common due to its crucial role in cellular health, red blood cell formation, and fetal development. Products like Merck’s Arcofolin L-Methylfolate represent a new generation of folate supplements designed for enhanced bioavailability and metabolic efficiency. This trend is particularly pronounced in North America, Europe, and emerging markets in Asia-Pacific, where health-conscious lifestyles and increased awareness are driving consistent growth in the consumption of Vitamin B9-enriched supplements.
Key Market Players
Report Scope
In this report, the Global Vitamin B9 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B9 Market.
Available Customizations
Global Vitamin B9 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Global Vitamin B9 Market was valued at USD 87.10 Million in 2024 and is projected to reach USD 106.91 Million by 2030, growing at a CAGR of 2.45%. Vitamin B9, also known as folate or folic acid, is essential for DNA synthesis, red blood cell production, and fetal development, making it a critical nutrient across various life stages, particularly during pregnancy. Rising focus on preventive healthcare and increased consumer awareness about nutritional deficiencies are driving demand for Vitamin B9 supplements, especially in North America and Europe. Government initiatives aimed at reducing anemia and neural tube defects in newborns have further encouraged folic acid fortification and supplementation. However, the market faces obstacles such as regulatory complexities, raw material price fluctuations, and the potential side effects of excessive intake. Despite these challenges, ongoing R&D investments, strategic partnerships, and expansion into underpenetrated regions are expected to shape the market's growth trajectory.
Key Market Drivers
Growth in Pharmaceutical Industry
The expanding pharmaceutical industry serves as a key driver for the Vitamin B9 market, fueled by the sector’s focus on disease prevention, prenatal health, and nutritional therapies. By 2023, the pharmaceutical market had reached revenues of approximately USD 1.6 trillion, highlighting its global scale and influence. Vitamin B9 is indispensable in therapeutic applications due to its roles in cell division, DNA synthesis, and hematopoiesis. It is extensively used in prenatal supplements to prevent neural tube defects and is increasingly incorporated into treatments for anemia, cognitive decline, and cardiovascular health. The market has seen innovations like Manna iStrong, a fortified drink launched by Southern Health Foods Pvt Ltd. in India, which delivers 100% of the RDA for Vitamin B9 among others. In regions where fortified foods are less accessible, pharmaceutical-grade supplements are vital, particularly in maternal and elderly care segments.
Key Market Challenges
Raw Material Supply Disruptions
Raw material supply instability presents a significant hurdle for Vitamin B9 manufacturers. The market is highly dependent on specific chemical intermediates and ingredients, predominantly sourced from a few global suppliers. Events such as geopolitical tensions, trade regulations, and natural disasters, as well as pandemics like COVID-19, have exposed vulnerabilities in the global supply chain. Countries such as China and India play critical roles in supplying active pharmaceutical ingredients (APIs) and intermediates, meaning regulatory changes or environmental policy shifts in these regions can disrupt production. These constraints not only elevate costs but also introduce delays and uncertainty for manufacturers, particularly small and medium-sized enterprises.
Key Market Trends
Increasing Demand for Dietary Supplements
The growing global emphasis on preventive healthcare is fueling demand for dietary supplements, making it a defining trend in the Vitamin B9 market. Consumers are increasingly turning to supplements to support immune function, address nutritional gaps, and reduce disease risk. Folic acid’s inclusion in multivitamins and prenatal products is becoming more common due to its crucial role in cellular health, red blood cell formation, and fetal development. Products like Merck’s Arcofolin L-Methylfolate represent a new generation of folate supplements designed for enhanced bioavailability and metabolic efficiency. This trend is particularly pronounced in North America, Europe, and emerging markets in Asia-Pacific, where health-conscious lifestyles and increased awareness are driving consistent growth in the consumption of Vitamin B9-enriched supplements.
Key Market Players
- Anhui Xinhong Chemical Co., Ltd
- Changzhou Niutang Chemical Plant Co., Ltd.
- Zhejiang Shengda Bio-Pharm Co., Ltd.
- Xinfa Pharmaceutical Co., Ltd.
- Jiangxi Tianxin Pharmaceutical Co., Ltd.
- Hebei Jiheng (Group) Pharmaceutical Co., Ltd.
Report Scope
In this report, the Global Vitamin B9 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Vitamin B9 Market, By Sales Channel:
- Direct
- Indirect
- Vitamin B9 Market, By End Use:
- Pharmaceutical
- Food
- Animal Feed
- Cosmetic & Personal Care
- Others
- Vitamin B9 Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B9 Market.
Available Customizations
Global Vitamin B9 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. IMPACT OF COVID-19 ON GLOBAL VITAMIN B9 MARKET
5. GLOBAL VITAMIN B9 MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Sales Channel (Direct, Indirect)
5.2.2. By End Use (Pharmaceutical, Food, Animal Feed ,Cosmetic & Personal Care, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. NORTH AMERICA VITAMIN B9 MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Sales Channel
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Vitamin B9 Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Sales Channel
6.3.1.2.2. By End Use
6.3.2. Mexico Vitamin B9 Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Sales Channel
6.3.2.2.2. By End Use
6.3.3. Canada Vitamin B9 Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Sales Channel
6.3.3.2.2. By End Use
7. EUROPE VITAMIN B9 MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Sales Channel
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Vitamin B9 Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Sales Channel
7.3.1.2.2. By End Use
7.3.2. Germany Vitamin B9 Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Sales Channel
7.3.2.2.2. By End Use
7.3.3. United Kingdom Vitamin B9 Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Sales Channel
7.3.3.2.2. By End Use
7.3.4. Italy Vitamin B9 Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Sales Channel
7.3.4.2.2. By End Use
7.3.5. Spain Vitamin B9 Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Sales Channel
7.3.5.2.2. By End Use
8. ASIA PACIFIC VITAMIN B9 MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Sales Channel
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Vitamin B9 Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Sales Channel
8.3.1.2.2. By End Use
8.3.2. India Vitamin B9 Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Sales Channel
8.3.2.2.2. By End Use
8.3.3. South Korea Vitamin B9 Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Sales Channel
8.3.3.2.2. By End Use
8.3.4. Japan Vitamin B9 Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Sales Channel
8.3.4.2.2. By End Use
8.3.5. Australia Vitamin B9 Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Sales Channel
8.3.5.2.2. By End Use
9. SOUTH AMERICA VITAMIN B9 MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Sales Channel
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Vitamin B9 Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Sales Channel
9.3.1.2.2. By End Use
9.3.2. Argentina Vitamin B9 Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Sales Channel
9.3.2.2.2. By End Use
9.3.3. Colombia Vitamin B9 Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Sales Channel
9.3.3.2.2. By End Use
10. MIDDLE EAST AND AFRICA VITAMIN B9 MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Sales Channel
10.2.2. By End Use
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Vitamin B9 Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Sales Channel
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Vitamin B9 Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Sales Channel
10.3.2.2.2. By End Use
10.3.3. UAE Vitamin B9 Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Sales Channel
10.3.3.2.2. By End Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL VITAMIN B9 MARKET: SWOT ANALYSIS
14. PORTERS FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Anhui Xinhong Chemical Co., Ltd
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Changzhou Niutang Chemical Plant Co., Ltd.
15.3. Zhejiang Shengda Bio-Pharm Co., Ltd.
15.4. Xinfa Pharmaceutical Co., Ltd.
15.5. Jiangxi Tianxin Pharmaceutical Co., Ltd.
15.6. Hebei Jiheng (Group) Pharmaceutical Co., Ltd.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. IMPACT OF COVID-19 ON GLOBAL VITAMIN B9 MARKET
5. GLOBAL VITAMIN B9 MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Sales Channel (Direct, Indirect)
5.2.2. By End Use (Pharmaceutical, Food, Animal Feed ,Cosmetic & Personal Care, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. NORTH AMERICA VITAMIN B9 MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Sales Channel
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Vitamin B9 Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Sales Channel
6.3.1.2.2. By End Use
6.3.2. Mexico Vitamin B9 Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Sales Channel
6.3.2.2.2. By End Use
6.3.3. Canada Vitamin B9 Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Sales Channel
6.3.3.2.2. By End Use
7. EUROPE VITAMIN B9 MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Sales Channel
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Vitamin B9 Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Sales Channel
7.3.1.2.2. By End Use
7.3.2. Germany Vitamin B9 Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Sales Channel
7.3.2.2.2. By End Use
7.3.3. United Kingdom Vitamin B9 Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Sales Channel
7.3.3.2.2. By End Use
7.3.4. Italy Vitamin B9 Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Sales Channel
7.3.4.2.2. By End Use
7.3.5. Spain Vitamin B9 Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Sales Channel
7.3.5.2.2. By End Use
8. ASIA PACIFIC VITAMIN B9 MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Sales Channel
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Vitamin B9 Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Sales Channel
8.3.1.2.2. By End Use
8.3.2. India Vitamin B9 Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Sales Channel
8.3.2.2.2. By End Use
8.3.3. South Korea Vitamin B9 Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Sales Channel
8.3.3.2.2. By End Use
8.3.4. Japan Vitamin B9 Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Sales Channel
8.3.4.2.2. By End Use
8.3.5. Australia Vitamin B9 Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Sales Channel
8.3.5.2.2. By End Use
9. SOUTH AMERICA VITAMIN B9 MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Sales Channel
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Vitamin B9 Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Sales Channel
9.3.1.2.2. By End Use
9.3.2. Argentina Vitamin B9 Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Sales Channel
9.3.2.2.2. By End Use
9.3.3. Colombia Vitamin B9 Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Sales Channel
9.3.3.2.2. By End Use
10. MIDDLE EAST AND AFRICA VITAMIN B9 MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Sales Channel
10.2.2. By End Use
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Vitamin B9 Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Sales Channel
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Vitamin B9 Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Sales Channel
10.3.2.2.2. By End Use
10.3.3. UAE Vitamin B9 Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Sales Channel
10.3.3.2.2. By End Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL VITAMIN B9 MARKET: SWOT ANALYSIS
14. PORTERS FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Anhui Xinhong Chemical Co., Ltd
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Changzhou Niutang Chemical Plant Co., Ltd.
15.3. Zhejiang Shengda Bio-Pharm Co., Ltd.
15.4. Xinfa Pharmaceutical Co., Ltd.
15.5. Jiangxi Tianxin Pharmaceutical Co., Ltd.
15.6. Hebei Jiheng (Group) Pharmaceutical Co., Ltd.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
